{
    "xml": "<topic id=\"PHP80918\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/exelon-patches\" basename=\"exelon-patches\" title=\"Exelon patches\">\n<title>Exelon<tm tmtype=\"reg\"/> patches</title>\n<topic id=\"PHP81252\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/clinical-medicinal-product-information/exelon-patches\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Advise patients and carers of patch administration instructions, particularly to remove the previous day's patch before applying the new patch&#8212;consult product literature.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP81254\" outputclass=\"nationalFunding\" rev=\"1.8\" parent=\"/clinical-medicinal-product-information/exelon-patches\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (October 2007) that <i>Exelon</i>\n<tm tmtype=\"reg\"/> patches should be restricted for use in patients with moderately severe Alzheimer&#8217;s disease under the conditions of the NICE guidance (September 2007) and when a transdermal patch is an appropriate choice of formulation.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP80918",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/exelon-patches",
    "basename": "exelon-patches",
    "title": "Exelon patches",
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Advise patients and carers of patch administration instructions, particularly to remove the previous day's patch before applying the new patch&#8212;consult product literature.",
                "html": "<p>Advise patients and carers of patch administration instructions, particularly to remove the previous day's patch before applying the new patch&#8212;consult product literature.</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (October 2007) that Exelon patches should be restricted for use in patients with moderately severe Alzheimer&#8217;s disease under the conditions of the NICE guidance (September 2007) and when a transdermal patch is an appropriate choice of formulation.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (October 2007) that <i>Exelon</i> <tm tmtype=\"reg\"/> patches should be restricted for use in patients with moderately severe Alzheimer&#8217;s disease under the conditions of the NICE guidance (September 2007) and when a transdermal patch is an appropriate choice of formulation.</p>"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}